ColgatePalmolive (CL)
(Delayed Data from NYSE)
$100.46 USD
-0.07 (-0.07%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $100.50 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$100.46 USD
-0.07 (-0.07%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $100.50 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Zacks News
Colgate's (CL) Growth Initiatives On Track, Cost Woes Persist
by Zacks Equity Research
Colgate (CL) witnesses soft margins on increased raw material costs, higher SG&A expenses and currency woes. However, its innovation plans, savings program and expansion strategies might help.
Colgate Down 6% in 3 Months: Can Growth Efforts Revive Stock?
by Zacks Equity Research
Colgate (CL) is grappling with weak margins and adverse impacts of foreign currency. Nevertheless, its innovation plans, savings program and expansion strategies bode well.
The Zacks Analyst Blog Highlights: ExxonMobil, Starbucks, Diageo, Fidelity National Information Services and Colgate-Palmolive
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ExxonMobil, Starbucks, Diageo, Fidelity National Information Services and Colgate-Palmolive
Top Stock Reports for ExxonMobil, Starbucks & Diageo
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including ExxonMobil (XOM), Starbucks (SBUX) and Diageo (DEO).
Stocks & ETFs to Profit From Cyber Monday Deals
by Sweta Killa
While investing in any of the retail stocks could reward investors throughout Cyber Week, a diverse approach in a basket form can also be a great choice.
Colgate-Palmolive (CL) Down 1.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Soap & Cleaning Materials Stock Outlook Buoyant on Innovation
by Rajani Lohia
The FMCG space gains from continued investment in brands, innovation, cost-containment and pricing actions. Escalating operating costs and unfavorable currency rates are headwinds.
Colgate (CL) Earnings Surpass Estimates in Q3, Sales Miss
by Zacks Equity Research
Colgate (CL) beats third-quarter 2019 earnings estimates on strong volume and pricing gains.
Colgate-Palmolive (CL) Q3 Earnings Beat Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 1.43% and -0.74%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Things You Need to Know Before Colgate's (CL) Q3 Earnings
by Zacks Equity Research
Higher raw material and SG&A costs, and adverse currency are likely to get reflected in Colgate's (CL) third-quarter margins and earnings. However, pricing gains and innovation might have offset woes.
Analysts Estimate Colgate-Palmolive (CL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ecolab's (ECL) Gallay Medical Buyout to Boost Healthcare Arm
by Zacks Equity Research
The addition of Gallay Medical is likely to boost Ecolab's (ECL) Healthcare offerings.
Colgate's (CL) Growth Efforts on Track, Cost Woes Persist
by Zacks Equity Research
Colgate (CL) is grappling with weak margin trend and adverse impacts of currency. Nevertheless, its accelerated investments in brands, higher pricing and strong innovations bode well for growth.
Has Colgate-Palmolive (CL) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (CL) Outperforming Other Consumer Staples Stocks This Year?
Here's Why Procter & Gamble Stock is Worth Betting on Now
by Zacks Equity Research
Procter & Gamble's (PG) focus on improving its product portfolio through strategic initiatives bodes well. Also, the company is on track with its cost-saving plans.
Clorox (CLX) Declines Post Soft FY20 View: Is This Temporary?
by Zacks Equity Research
Headwinds in the Charcoal, and Bags and Wraps businesses are hurting Clorox's (CLX) sales performance. But its robust fundamentals, initiatives and earnings trend indicate solid long-term prospects.
Colgate (CL) Displays a Solid Run-Up of More Than 20% YTD
by Zacks Equity Research
Colgate (CL) is benefiting from higher pricing, strong innovation and expansion efforts. Moreover, the company's savings programs are delivering impressive result.
Colgate-Palmolive (CL) Up 0.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Procter & Gamble is a Hot Investment Pick Now
by Zacks Equity Research
Procter & Gamble (PG) is benefiting from ongoing initiatives to improve productivity. Also, the company is focused on product improvement, packaging and marketing initiatives and cost-saving plans.
Church & Dwight Likely to Keep Gaining on Solid Sales Trend
by Zacks Equity Research
Church & Dwight's (CHD) sales are gaining from continued category growth and healthy market share gains. The company's consumer international business has long been contributing to the top line.
Clorox (CLX) Q4 Earnings Top Estimates, Soft View Hurts Stock
by Zacks Equity Research
Clorox (CLX) reports mixed fourth-quarter fiscal 2019 results. Lower taxes and gross margin expansion aid its earnings while lower volume and unfavorable currency hurt sales.
Procter & Gamble (PG) Stock Up on Q4 Earnings & Sales Beat
by Zacks Equity Research
Procter & Gamble (PG) posts robust fourth-quarter fiscal 2019 results. Also, the company provided upbeat guidance for fiscal 2020.
Colgate (CL) Q2 Earnings & Sales Miss Estimates, Decline Y/Y
by Zacks Equity Research
Colgate (CL) posts lower-than-expected second-quarter 2019 results. Foreign currency translations remain a major headwind in the quarter.
Colgate-Palmolive (CL) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of -1.37% and -0.02%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Why Colgate-Palmolive (CL) Might Surprise This Earnings Season
by Zacks Equity Research
Colgate-Palmolive (CL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.